Whitepaper
28 Mar 2025

Venus Remedies Secures Registrations for its Unit-2 in Baddi and Venus Pharma GmbH from Kuwait

PNG 213 kB

Venus Remedies Limited is delighted to announce the successful registration of our Unit-2 in Baddi and Venus Pharma GmbH from Kuwait, alongside obtaining Marketing Authorizations (MAs) for Carboplatin 450 MG/45 ML. These achievements mark significant milestones in our ongoing commitment to expanding our global footprint and enhancing our pharmaceutical capabilities.

Content provided by our supplier

Venus Pharma GmbH

  • DE
  • 2019
    On CPHI since
  • 5
    Certificates
  • 1000 - 4999
    Employees
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Clinical Research
Contract Manufacturer
Contract Research Organisation
Custom Manufacturing/Custom Synthesis
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Regulatory Affairs

Other Content from Venus Pharma GmbH (9)

  • Video Venus Remedies and West Pharmaceutical (vendor testimonal)

    Venus Remedies and West Pharmaceutical Packaging @westatwork Kriti Kotian, Marketing Specialist at West Pharmaceutical Packaging India.
  • Podcast Mr. Abednego Njalale - Podcast

    Join Venus Remedies and Venus Pharma GmbH at CPhI Milan 2024, from October 8th to 10th, in Hall 14, Meeting Rooms G52 & G54.
  • Whitepaper Venus Remedies Global Presence -96+ countries

    Venus Remedies Global Presence -96+ countries
  • Video Global Presence

    Venus Remedies: A Global Pharma Force with Presence in 100 Countries and 800+ Marketing Authorizations
  • Video Anticancer Products

    Venus Pharma GmbH is committed to the fight against cancer through itsadvanced range of Anticancer Injectables. Our products are designed to provide effective treatment options that address the unique needsof cancer patients. With a focus on precision, safety, and innovation, our injectables are developed using state-of-the-art technologies and rigorous quality standards. We aim to enhance patient outcomes and improve quality of life through therapies that target cancer at its core while minimizing adverse effects.

  • Datasheet What an incredible final day at CPhI 2024!

    What an incredible final day at CPhI 2024! Venus Remedies wrapped up this amazing event with innovative showcases and powerful conversations with industry leaders. Thank you to everyone who joined us on this journey! Swipe to catch day 3 highlights!
  • Datasheet Accreditation

    Our efforts are well recognitioned by global regulatory authorities.Venus's passion for quality is reflected in its ability to align its organization-wide operations to global standards enabling it to secure global and national endorsements – its manufacturing facilities have thus far obtained more than 20 gmp approvals.
  • Report Venus Remedies is a leading Meropenem Manufacturer in India that exports worldwide

    Venus Meropenem is revolutionizing the fight against serious bacterial infections. With its broad-spectrum action, it effectively targets conditions like pneumonia and urinary tract infections, providing healthcare professionals with a reliable solution. This innovative antibiotic exemplifies the advancements in medical treatment, ensuring better outcomes for patients facing complex infections.

Recently Visited